Mr Gianluca Fabiano

Gianluca Fabiano

Contact

Research project: Value of pharmaceutical innovation

Abstract

My research focuses on the process of pharmaceutical innovation with the aim of investigating the role played by different public and private actors. 

Biography

I am a PhD student at Kingston University and I collaborate in research projects in Health Economics with the Centre for Economic and International Studies (CEIS-EEHTA) of the University of Rome "Tor Vergata" where I obtained a Master Degree in Economics in 2015. Previously, I studied at "Roma Tre" University gaining a Bachelor Degree in Political Economy and at the Universitat Pompeu Fabra (UPF) in Barcelona as part of the Erasmus programme. I also held a placement at Kingston University London as a winner of the Erasmus + Traineeship. Recently I attended a short course in "Decision Analytic Modelling for Economic Evaluation" provided by the University of Glasgow and the "Building a Budget Impact Model: Budget Impact Analysis Training" course organized by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). My research focuses on health economics and I am interested in the study of public policies applied to the health sector.

Areas of research interest

  • Health economics
  • Health technology assessment
  • Economic evaluation
  • Public economics

Qualifications

  • MRes in Management and Business Studies Research, Kingston University London
  • MSc in Economics, University of Rome
  • BSc in Political Economy, University of Roma Tre
  • Associate Fellow of Higher Education Academy (AFHEA)

Funding or awards received

  • Graduate Teaching Assistant

Publications

  • Mennini, F. S., Fabiano, G., Favato, G., Sciattella, P., Bonanni, P., Pinto, C., & Marcellusi, A. (2019). Economic burden of HPV9-related diseases: a real-world cost analysis from Italy. The European Journal of Health Economics.
  • Mennini, F., Marcellusi, A., Fabiano, G., Rimassa, L., Santoro, A., & Personeni, N. (2019). Budget impact of bi-monthly use of Cetuximab in patients diagnosed with mCRC. Future Oncology. 
  • Mennini, F., Marcellusi, A., Fabiano, G., Platini, F., & Bossi, P. (2019). Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer. Head & Neck.
  • Marcellusi, A., Fabiano, G., Viti, R., Morel, P. C. F., Nicolò, G., Siracusano, A., & Mennini, F. S. (2018). Economic burden of schizophrenia in Italy: a probabilistic cost of illness analysis. BMJ open.
  • Ibrahim S., Noikokyris E., Fabiano G., Favato G. (2017), "Manipulation of Profits in Italian Publicly Funded Health Care Trusts", Public Money & Management

Conference papers

  • Poster and Oral Presentation: Public-Private Contribution to Biopharmaceutical Discoveries: a Bibliometric Analysis of Basic Research in UK", ISPOR 21th Annual European Congress, 10-14 November 2018, Barcelona, Spain; Congresso Nazionale SIHTA (Societa' Italiana HTA), Rome, 12 October 2018
  • Poster Presentation: "Human Papilloma Virus in Italy: Cost of Illness and Potential Savings Due to HPV9 Primary Prevention", ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, UK.
  • Oral Presentation: "Economic Impact of Macular Edema Diseases in Italy, a Retrospective study", HTAi 14th Annual Meeting, 17-21 June 2017, Rome, Italy.
  • Poster presentation: "Economic Impact of Macular Edema Diseases in Italy", ISPOR 19th Annual European Congress, 29 October-2 November 2016, Austria Center Vienna, Wien, Austria.
  • Poster Presentation: "Direct and Indirect Costs Associated with Retinal Vascular Diseases in Italy. A Probabilistic Cost of Illness Study", ISPOR 18th Annual European Congress, 7-11 November 2015, MiCo - Milano Congressi Milan, Italy, 

Search research students by name

Search research students by name
>

Search research students by research interests

Search research students by research interests
>